ScienceDex / Researcher record
Serrero, Ginette
- A and G Pharmaceutical, Inc. (no department on record)
From the FY2018 NIH awards this investigator leads as contact PI. The department is the award's.
- Long-Funded
NIH Funding · FY2018
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2007 | $120,600 | 1 | #35,942 |
| 2010 | $575,793 | 1 | #15,436 |
| 2011 | $691,398 | 2 | #10,885 |
| 2012 | $193,879 | 1 | #32,377 |
| 2013 | $69,737 | 1 | #37,906 |
| 2014 | $1,547,592 | 2 | #3,981 |
| 2017 | $1,307,315 | 2 | #4,906 |
| 2018 | $2,094,089 | 3 | #2,651 |
| 2021 | $141,660 | 1 | #40,581 |
| 2022 | $897,757 | 2 | #11,208 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20071 record
- FY20101 record
- FY20112 records
- FY20121 record
- FY20131 record
- FY20142 records
- FY20172 records
- FY2018 · selected3 records
- FY20211 record
- FY20222 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2007 through FY2022Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2018 award records by amount
NIH award records listing Serrero, Ginette as a PI. Multi-PI records show the full award amount for context.
- 2R44CA210817-02R44Contact PIA Circulating Biomarker for use in Monitoring Metastatic Breast Cancer$1.1Maward amount
- 5R44CA162629-03R44Contact PITargeted Therapy for Non Small Cell Lung Carcinoma: Human Phase 1 safety and dose escalation studies$833.4Kaward amount
- 1R44CA224718-01A1R44Contact PIPharmacology & human Phase 1 safety & dose escalation studies using anti-GP88 in aggressive breast cancer$159.4Kaward amount
Award organization
Organizations that administered FY2018 awards listing Serrero, Ginette as a PI.
FY2018 award administered by A and G Pharmaceutical, Inc. (MD).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2007First NIH AwardA and G Pharmaceutical, Inc.
- 2010$500K Cumulative Funding
- 2011$1M Cumulative Funding
- 2014$2M Cumulative Funding
- 2014Entered Top 50% NationallyRanked #3981
- 2014Entered Top 25% NationallyRanked #3981
- 2018$5M Cumulative Funding